Metformin has been reported to reduce the risk of COVID-19 severity [ 22 ]; while the present results showed a trend toward reduced risk, no significant difference was observed.
← all excerpts
Risk analysis of COVID-19 hospitalization and critical care by race and region in the United States: a cohort study.
1
—
—